For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Alectos Therapeutics Inc.

USPTO Granted Patents = 19

% Expired Patents = 63.2

CIPO Patents = 2

EPO Patents = 16

Forward Citations = 44

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

David Jaro Vocadlo (15 out of 22 patents)

4. Harold G Selnick (15 out of 102 patents)

5. Yongbao Zhu (10 out of 19 patents)

6. Ramesh Kaul (8 out of 12 patents)

7. Jianyu Sun (5 out of 25 patents)

8. Kun Liu (5 out of 48 patents)

9. Yaode Wang (4 out of 10 patents)

10. Zhongyong Wei (4 out of 8 patents)

11. Tong-Shuang Li (4 out of 9 patents)

12. Changwei Mu (3 out of 8 patents)

13. Ernest J Mceachern (3 out of 3 patents)

14. Jiang Chang (2 out of 15 patents)

15. Samy Cecioni (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 12528773 - NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF (2026-01-20),

2. 11396522 - Bis-acetal-based substrates for imaging exo-glycosidase activity (2022-07-26),

3. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),

4. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),

5. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),

6. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

7. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),

8. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),

9. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

10. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),

11. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

12. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),

13. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),

14. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),

15. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),

ALECTOS THERAPEUTICS INC. is a biopharmaceutical company dedicated to discovering and developing innovative drugs for the treatment of neurodegenerative diseases. With a focus on targeting protein misfolding and aggregation, ALECTOS aims to provide transformative therapies to patients suffering from Alzheimer's, Parkinson's, and other related disorders. Through a combination of cutting-edge research, strategic partnerships, and a passionate team of scientists, ALECTOS is committed to making a positive impact on the lives of millions affected by debilitating neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

19 Patents

#24 in Burnaby

#778 in Canada

#32,571 in the World

Burnaby, Canada

Alectos Therapeutics Inc.

Forward Citations = 44

21 inventors:

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

David Jaro Vocadlo (15 out of 22 patents)

4. Harold G Selnick (15 out of 102 patents)

5. Yongbao Zhu (10 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…